Metabonomic characterization of early atherosclerosis in hamsters with induced cholesterol

References

• A JY, Trygg J, Gullberg J, Johansson A, Jonsson P, Antti H, Marklund S, Moritz T. (2005). Extraction and GC/MS analysis of the human blood plasma metabolome. Anal Chem 77:8086–94.
   PubMed Web of Science ®Google Scholar
• Allain CC, Poon LS, Chen CS, Richmond W, Fu PC. (1974). Enzymatic determination of total serum cholesterol. Clin Chem 20:470–5.
   PubMed Web of Science ®Google Scholar
• Antoku Y, Tsukamoto K, Miyoshi Y, Nagino H, Anezaki M, Suwa K, Narabe Y. (2000). Correlations of elevated levels of hexacosanoate in erythrocyte membranes with risk factors for atherosclerosis. Atherosclerosis 153:169–73.
   PubMed Web of Science ®Google Scholar
• Bijnens AP, Lutgens E, Ayoubi T, Kuiper J, Horrevoets AJ, Daemen MJAP. (2006). Genome-wide expression studies of atherosclerosis: critical issues in methodology, analysis, interpretation of transcriptomics data. Arterioscler Thromb Vasc Biol 26:1226–35.
   PubMed Web of Science ®Google Scholar
• Brindle JT, Antti H, Holmes E, Tranter G, Nicholson JK, Bethell HWL, Clarke S, Schofield, PM, Mckilligin E, Mosedale DE, Grainger DJ. (2002). Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med 8:1439–44.
   PubMed Web of Science ®Google Scholar
• Bucolo G, David H. (1973). Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 36:476–82.
   Google Scholar
• Daumerie CE, Woollett LA, Dietschy JM. (1992). Fatty acids regulate hepatic low density lipoprotein receptor activity through redistribution of intracellular cholesterol pools. Proc Natl Acad Sci USA 89:10797–801.
   PubMed Web of Science ®Google Scholar
• Dumas ME, Barton RH, Toye A, Cloarec O, Blancher C, Rothwell A, Fearnside J, Tatoud R, Blanc V, Lindon J, Mitchell SC, Holmes E, McCarthy MI, Scott J, Gauguier D, Nicholson JK. (2006). Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci USA 103:1511–16.
   Web of Science ®Google Scholar
• Eriksson L, Johansson E, Kettaneh-Wold N, Wold S. (2001). Multi- and megavariate data analysis principles and applications. Umea, Sweden: Umetrics Academy, Umetrics AB.
   Google Scholar
• Hui DY. (2003). HIV protease inhibitors and atherosclerosis. J Clin Invest 111:317–18.
   PubMed Web of Science ®Google Scholar
• Jonsson P, Johansson AI, Gullberg J, Trygg J, A JY, Grung B, Marklund S, Sjöström M, Antti H, Moritz T. (2005). High-throughput data analysis for detecting and identifying differences between samples in GC/MS-Based metabolomic analyses. Anal Chem 77:5635–42.
   PubMed Web of Science ®Google Scholar
• Kenny LC, Dunn WB, Ellis DI, Myers J, Baker PN, Kell DB. (2005). Novel biomarkers for pre-eclampsia detected using metabolomics and machine learning. Metabolomics 1:227–34.
   Web of Science ®Google Scholar
• Kleemann R, Verschuren L, Erk MJ, Nikolsky Y, Cnubben NHP, Verheij ER, Smilde AK, Hendriks HFJ, Zadelaar S, Smith GJ, Kaznacheev V, Nikolskaya T, Melnikov A, Hurt-Camejo E, Greef J, Ommen B, Kooistra T. (2007). Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis. Genome Biol 8:R200.
   PubMed Web of Science ®Google Scholar
• Kris-Etherton PM, Dietschy J. (1997). Design criteria for studies examining individual fatty acid effects on cardiovascular disease risk factors: human and animal studies. Am J Clin Nutr 65 (Suppl.):1590S–6S.
   Google Scholar
• Lahoz C, Mostaza, JM. (2007). Atherosclerosis as a systemic disease. Rev Esp Cardiol 60:184–95.
   PubMed Web of Science ®Google Scholar
• Lescano-De-Souza AJ, Curi R. (1999). Cholesterol inhibits glutamine metabolism in LLC WRC256 tumour cells but does not affect it in lymphocytes: possible implications for tumour cell proliferation. Cell Biochem Funct 17:223–38.
   PubMed Web of Science ®Google Scholar
• Lusis AJ. (2000). Atherosclerosis. Nature 407:233–41.
   PubMed Web of Science ®Google Scholar
• Mayr M, Chung Y, Mayr U, Yin X, Ly L, Troy H, Fredericks S, Hu Y, Griffiths JR, Xu Q. (2005). Proteomic and metabolomic analyses of atherosclerotic vessels from apolipoprotein E-deficient mice reveal alterations in inflammation, oxidative stress, and energy metabolism. Arterioscler Thromb Vasc Biol 25:2135–42.
   PubMed Web of Science ®Google Scholar
• Nicholson J, Lindon, J, Holmes E. (1999). ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis for biological NMR spectroscopic data. Xenobiotica 29:1181–9.
   PubMed Web of Science ®Google Scholar
• Nistor A, Bulla A, Filip DA, Radu A. (1987). The hyperlipidemic hamster as a model of experimental atherosclerosis. Atherosclerosis 68:159–73.
   PubMed Web of Science ®Google Scholar
• Sabatine MS, Liu E, Morrow DA, Heller E, McCarroll R, Wiegand R, Berriz GF, Roth FP, Gerszten RE. (2005). Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 112:3868–75.
   PubMed Web of Science ®Google Scholar
• Sato T, Saito T, Yoshinaga K. (1985). The chemical composition of the thoracic aorta in diabetic and non-diabetic rats. Tohoku J Exp Med 147:357–64.
   PubMed Web of Science ®Google Scholar
• Steinberg D. (2002). Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 8:1211–17.
   PubMed Web of Science ®Google Scholar
• Sung HJ, Ryang YS, Jang SW, Lee CW, Han KH, Ko J. (2006). Proteomic analysis of differential protein expression in atherosclerosis. Biomarkers 11:279–90.
   PubMed Web of Science ®Google Scholar
• Trygg J, Lundstedt T. (2007). Chemometrics techniques for metabonomics. J Proteome Res 6:469–79.
   PubMed Web of Science ®Google Scholar
• Tuomisto TT, Binder BR, Ylä-Herttuala S. (2005). Genetics, genomics and proteomics in atherosclerosis research. Ann Med 37:323–32.
   PubMed Web of Science ®Google Scholar
• Weingand KW, Daggy BP. (1990). Quantitation of high-density lipoprotein cholesterol in plasma from hamsters by differential precipitation. Clin Chem 36:575.
   PubMed Web of Science ®Google Scholar
• Wold S. (1978). Cross-validatory estimation of the number of components in factor and principal components models. Technometrics 20:397–405.
   Web of Science ®Google Scholar
• Woollett LA, Spady DK, Dietschy JM. (1992). Regulatory effects of the saturated fatty acids 6:0 through 18:0 on hepatic low density lipoprotein receptor activity in the hamster. J Clin Invest 89:1133–41.
   PubMed Web of Science ®Google Scholar
• Yi LZ, Yuan DL, Che ZH, Liang YZ, Zhou ZG, Gao HY, Wang YM. (2008). Plasma fatty acid metabolic profile coupled with uncorrelated linear discriminant analysis to diagnose and biomarker screening of type 2 diabetes and type 2 diabetic coronary heart diseases. Metabolomics 4:30–8.
   Web of Science ®Google Scholar